Evidence Synthesis
Standard Shift Narrative for AMRAPLIN on October 21, 2026.
The Indian equity market witnessed a to quarterly cadence for AMRAPLIN, with no change in the metric.
On the sector front, AMRAPLIN's to quarterly cadence indicates a .67x acceleration in marginal operating leverage.
In terms of revenue growth, AMRAPLIN's .3% quarterly cadence marks a to deceleration from the previous quarter.
The daily trading volume of AMRAPLIN decreased to 4,142 shares, a decline of 0.397 shares from the previous day's volume of 9,713 shares.
The close price of AMRAPLIN ended at 35.11 INR, a decrease of 0.015 INR from the previous day's close price of 35.87 INR.